FLUOROALKYL-SUBSTITUTED LITHIUM 1,3-DIKETONATES
775
1
1560 m (C=N, C=C). H NMR spectrum (CDCl3), δ,
s (CF3). Found, %: C 60.28; H 4.07; F 17.61; N 17.83.
C16H13F3N4. Calculated, %: C 60.38; H 4.12; F 17.91;
N 17.60.
ppm: 1.76–1.86 m (4H, CH2), 2.71–2.81 m (4H, CH2),
2.37 s (3H, Me), 5.63 br.s (NH2), 7.08 s (1H, CH),
7.82 t (HCF2, JHF = 54.5 Hz). 13C NMR spectrum
2
7-[3-(Difluoromethyl)-5-phenyl-1H-pyrazol-
1-yl]-6-fluoroquinoxaline (IVe). b. From 0.6 g
(2.9 mmol) of diketonate Ia and 0.5 g (2.9 mmol) of
hydrazine IIc we obtained 0.9 g (92%) of compound
IVe. White powder, mp 134–135°C. IR spectrum, ν,
cm–1: 1510 s, 1490 m (C=N, C=C). 1H NMR spectrum
(CDCl3), δC, ppm: 21.19 s, 22.66 s, 22.70 s, 23.62 s,
1
24.20 s, 99.62 s, 110.38 t (HCF2, JCF = 235.38 Hz),
121.77 t (4JCF = 1.14 Hz), 132.89 t (2JCF = 31.0 Hz),
152.61 t (3JCF = 2.1 Hz), 159.39 s, 161.91 s, 170.31 s.
19F NMR spectrum (CDCl3): δF 48.04 ppm, d.d.d
2
5
(HCF2, JFH = 54.5, JFH = 2.9, 2.8 Hz). Found, %:
C 55.87; H 5.49; F 13.58; N 25.16. C13H15F2N5. Cal-
culated, %: C 55.91; H 5.41; F 13.60; N 25.07.
(CDCl3), δ, ppm: 6.81 t (HCF2, 2JHF = 54.7 Hz), 6.83 s
3
(1H, CH), 7.23–7.35 m (5H, Ph), 7.79 d (1H, JHF
=
=
3
10 Hz), 8.29 d (1H, 4JHF = 7.6 Hz), 8.88 d (1H, JHH
1.7 Hz), 8.90 d (1H, JHH = 1.7 Hz). 19F NMR spec-
trum (CDCl3), δF, ppm: 49.42 d (HCF2, 2JHF = 54.7 Hz),
46.25 d.d (1F, 6-F, 3JFH = 10.00, 4JFH = 7.6 Hz). Found,
%: C 63.55; H 3.24; F 16.76; N 16.44. C18H11F3N4.
Calculated, %: C 63.53; H 3.26; F 16.75; N 16.46.
3
4-Methyl-6-[5-(trifluoromethyl)-4,5,6,7-tetra-
hydro-2H-indazol-2-yl]pyrimidin-2-amine (Vg).
b. From 1.05 g (0.0052 mol) of diketonate Ig and
0.65 g (0.0052 mol) of hydrazine IIa we obtained
1.1 g (71%) of compound Vg. White powder, mp 202–
203°C. IR spectrum, ν, cm–1: 3496, 3288, 3138 (NH),
6-Fluoro-7-[3-phenyl-5-(trifluoromethyl)-1H-
pyrazol-1-yl]quinoxaline (Vi) and 6-fluoro-7-
[5-phenyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-
quinoxaline (IVf). b. From 0.93 g (4.2 mmol) of
diketonate Ib and 0.74 g (4.2 mmol) of hydrazine IIc
we obtained a mixture of compounds Vi and IVf at
a ratio of 1:1. Yield 0.9 g (60%), white powder. The
1H and 19F NMR spectra each contained two sets of
1
1637 s, 1572 m (C=N, C=C). H NMR spectrum
(CDCl3), δ, ppm: 1.75–1.86 (4H, CH2), 2.39 s (3H,
Me), 2.73–2.77 m (4H, CH2), 5.13 br.s (2H, NH2),
6.97 m (1H, CH). 19F NMR spectrum (CDCl3):
δF 106.23 ppm, m (CF3). Found, %: C 52.57; H 4.84;
F 19.19; N 23.51. C13H14F3N5. Calculated, %: C 52.52;
H 4.75; F 19.17; N 23.56.
1
6-[3-(Difluoromethyl)-5-phenyl-1H-pyrazol-
1-yl]-2,4-dimethylpyrimidine (IVd). b. From 0.5 g
(2.4 mmol) of diketonate Ia and 0.34 g (2.4 mmol) of
hydrazine IIb we obtained 0.4 g (56%) of compound
IVd. White powder, mp 89–90°C. IR spectrum, ν,
cm–1: 1605 s, 1549 m (C=N, C=C). 1H NMR spectrum
(CDCl3), δ, ppm: 2.38 s (6H, Me), 6.73 s (1H, CH),
signals. H NMR spectrum (CDCl3), δ, ppm: IVf:
6.86 s (1H, CH), 7.24–7.37 m (5H, Ph), 7.78 d (1H,
3JHF = 9.9 Hz), 8.34 d (1H, 4JHF = 7.8 Hz), 8.89 d (1H,
JHH = 2.3 Hz), 8.90 d (1H, JHH = 2.3 Hz); Vi: 7.21 s
(1H, CH), 7.38–7.47 m (3H) and 7.86–7.88 m (2H)
3
4
(Ph), 7.97 d (1H, JHF = 9.8 Hz), 8.36 d (1H, JHF
=
3
7.9 Hz), 8.94 d (1H, JHH = 1.68 Hz), 8.95 d (1H,
2
3JHH = 1.68 Hz). 19F NMR spectrum (CDCl3), δF, ppm:
6.85 t (HCF2, JHF = 54.6 Hz), 6.96 s (1H, CH), 7.26–
7.34 m (5H, Ph). 13C NMR spectrum (CDCl3), δC,
3
IVf: 99.32 s (3F, CF3), 46.13 d.d (1F, 6-F, JFH = 9.9,
1
4JFH = 7.8 Hz); Vi: 102.75 d (3F, CF3, JFF = 4.88 Hz),
44.82 m (1F, 6-F). Found, %: C 60.35; H 2.83;
F 21.29; N 15.62. C18H10F4N4. Calculated, %: C 60.34;
H 2.81; F 21.21; N 15.64.
ppm: 23.73 s, 106.16 s, 111.16 t (HCF2, JCF
=
233.9 Hz), 118.98 s, 127.93 s, 128.42 s, 128.75 s,
130.97 s, 146.50 s, 148.48 t (2JCF = 30.5 Hz), 156.50 s,
19
169.03 s. F NMR spectrum (CDCl3): δF 49.47 ppm,
2
4
d.d (HCF2, JFH = 54.6, JFH = 1.0 Hz). Found, %:
C 63.95; H 4.71; F 12.61; N 18.70. C16H14F2N4. Cal-
culated, %: C 63.99; H 4.69; F 12.65; N 18.65.
2-[5-(Difluoromethyl)-3-phenyl-1H-pyrazol-
1-yl]-1,3-benzothiazole (Vk) and 2-[3-(difluoro-
methyl)-5-phenyl-1H-pyrazol-1-yl]-1,3-benzothia-
zole (IVg). b. From 0.6 g (2.9 mmol) of diketonate Ia
and 0.49 g (2.9 mmol) of hydrazine IId we obtained
a mixture of compounds Vk and IVg at a ratio of 1:3.
2,4-Dimethyl-3-phenyl-6-[5-(trifluoromethyl)-
1H-pyrazol-1-yl]pyrimidine (Vh). b. From 1 g
(4.5 mmol) of diketonate Ib and 0.62 g (4.5 mmol) of
hydrazine IIb we obtained 0.7 g (49%) of compound
Vh with mp 82.5–83.5°C. IR spectrum, ν, cm–1:
1
19
Yield 0.4 g (43%). The H and F NMR spectra each
1
contained two sets of signals. H NMR spectrum
1
2
1610 s, 1520 m (C=N, C=C). H NMR spectrum
(CDCl3), δ, ppm: IVg: 6.80 t (1H, HCF2, JHF
=
(CDCl3), δ, ppm: 2.59 s (6H, Me), 7.05 s (1H, CH),
7.21 s (1H, CH), 7.39–7.46 m (3H, Ph), 7.92–7.95 m
(2H, Ph). 19F NMR spectrum (CDCl3): δF 104.03 ppm,
54.6 Hz), 6.73 s (1H, CH), 7.38–7.54 m and 7.74–
7.80 m (9H, Harom); Vk: 7.17 s (1H, CH), 7.38–7.54 m
19
and 7.74–7.80 m (10H, HCF2, Harom). F NMR spec-
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY Vol. 50 No. 6 2014